Tuesday Morning EV/EBIT
Quel est le EV/EBIT de Tuesday Morning?
Le EV/EBIT de Tuesday Morning Corporation est N/A
Quelle est la définition de EV/EBIT?
Enterprise value to earnings before interest and taxes (EV/EBIT) is a financial ratio used to measure if a stock is priced appropriately to similar stocks and the market. It is similar to the P/E ratio.
ttm (trailing twelve months)
The EV/EBIT ratio addresses some of the shortcomings of the P/E ratio. Instead of taking market capitalization, the ratio uses enterprise value, as it takes into account the true value of the company. Enterprise value includes both equity and debt. It is calculated as:
Enterprise value = market cap + total debt – cash and cash equivalents
The EV/EBIT ratio is useful in comparing peers within the wider market. A high EV/EBIT ratio indicates that a company’s stock is overvalued. On the opposite, a low EV/EBIT ratio indicates that a company’s stock is undervalued. The lower the ratio, the more financially stable a company should be. However, investors and analyst should use other ratios and information to get a full picture of a company’s financial state and actual value.
EV/EBIT des entreprises dans Consumer Staples secteur sur OTC par rapport à Tuesday Morning
Que fait Tuesday Morning?
Tuesday Morning Corporation operates as an off-price retailer in the United States. The company offers various products, such as upscale home textiles, home furnishings, housewares, gourmet food products, pet supplies, bath and body products, toys, and seasonal décor products. As of June 30, 2020, it operated approximately 685 stores in 39 states. The company was founded in 1974 and is headquartered in Dallas, Texas. On May 27, 2020, Tuesday Morning Corporation, along with its affiliates, filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the Northern District of Texas.
Entreprises avec ev/ebit similaire à Tuesday Morning
- Tombill Mines a EV/EBIT de N/A
- DiaMedica Therapeutics a EV/EBIT de N/A
- Velodyne Lidar a EV/EBIT de N/A
- Qualigen Therapeutics a EV/EBIT de N/A
- NEXE Innovations a EV/EBIT de N/A
- Caladrius Biosciences Inc a EV/EBIT de N/A
- Tuesday Morning a EV/EBIT de N/A
- Galmed Pharmaceuticals Ltd a EV/EBIT de N/A
- Carpinienne de Participations a EV/EBIT de N/A
- Efficacious Elk Capital a EV/EBIT de N/A
- Extraction Oil & Gas a EV/EBIT de N/A
- Kiromic BioPharma a EV/EBIT de N/A
- Gold State Resources a EV/EBIT de N/A